Wednesday, August 30, 2017 3:39:55 PM
Schneider (financier) was given a 90 day extension. So were about halfway to the deadline, the company has not provided any guidance either way.
A few days after the 10th, Nemus also exercised the guaranty from entity tied to Schneider for the 20m.
Late September- early October we will know whether the deal is dead or not.
Regardless, should be able to complete a raise to file the INDs and start clinical trials in one of their candidates during first half of 2018
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM